Roof Advisory Group’s Bristol-Myers Squibb BMY Stock Holding History

Roof Advisory Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$4.04M	Buy	89,110 +7,760	+10%	+$361K	2.35%	18
2019 Q1	$3.88M	Buy	81,350 +3,720	+5%	+$185K	2.51%	18
2018 Q4	$4.04M	Buy	+77,630	New	+$4.17M	2.88%	14

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Roof Advisory Group's BMY Position: Q2 2019 in Review

Roof Advisory Group increased its Bristol-Myers Squibb (BMY) stake by 9.5% in Q2 2019, buying an estimated $361K and bringing the position to 89,110 shares worth $4.04M. The position accounts for 2.35% of the portfolio, ranked #18.

Roof Advisory Group first reported a position in BMY in Q4 2018 and has held it in 3 quarters since. 1,777 funds tracked by Wall St. Rank hold BMY as of Q2 2019.

Roof Advisory Group held 89,110 shares of Bristol-Myers Squibb worth $4.04M as of Q2 2019.
Roof Advisory Group bought 7,760 Bristol-Myers Squibb shares in Q2 2019, an estimated $361K.
Bristol-Myers Squibb made up 2.35% of Roof Advisory Group's portfolio in Q2 2019, its #18 holding.
Roof Advisory Group first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 3 quarters since.
1,777 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2019.

Based on Roof Advisory Group's 13F filing for Q2 2019, filed 8 Aug 2019.